Literature DB >> 7715746

Prilocaine elimination by isolated perfused rat lung and liver.

W P Geng1, M Ebke, H Foth.   

Abstract

Prilocaine is assumed to undergo significant elimination by extrahepatic organs and to differ in this respect from other commonly used local anaesthetics. In order to clarify whether the lung may play an important role as a site of elimination of prilocaine, the kinetic parameters were studied in isolated perfused rat lungs and were compared to those of isolated livers. Furthermore, the structurally related compounds bupivacaine and mepivacaine were also investigated in this system. Prilocaine was dispersed into a relatively large apparent distribution volume in perfused rat lung (139 ml versus 97 ml in controls). In single-pass perfused lungs the observed maximum of concentration was decreased by about 60% compared to controls. The mean residence time was prolonged by about 40%. These observations suggest that prilocaine is substantially retained by rat lung and that this effect occurs particularly during first-pass. However, the ability of rat lung to degrade prilocaine was relatively low. The clearance values were about 0.3 ml/min equal to about 20% of the hepatic capacity calculated per g of tissue. Thus it must be assumed that prilocaine is only transiently retained by the lung and will gain systemic availability later on. In rat lungs the kinetics of prilocaine elimination were not substantially different from those of bupivacaine and mepivacaine (16 and 12%). These observations do not support the assumption that especially prilocaine undergoes extrahepatic elimination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715746     DOI: 10.1007/bf00169069

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  7 in total

1.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

2.  First-pass uptake of verapamil, diazepam, and thiopental in the human lung.

Authors:  D L Roerig; K J Kotrly; C A Dawson; S B Ahlf; J F Gualtieri; J P Kampine
Journal:  Anesth Analg       Date:  1989-10       Impact factor: 5.108

3.  Toxic effects of local anaesthetic agents on the central nervous system.

Authors:  D B Scott
Journal:  Br J Anaesth       Date:  1986-07       Impact factor: 9.166

Review 4.  Pharmacokinetics of local anaesthetics.

Authors:  G T Tucker
Journal:  Br J Anaesth       Date:  1986-07       Impact factor: 9.166

5.  Pharmacokinetic aspects of intravenous regional anesthesia.

Authors:  G T Tucker; R A Boas
Journal:  Anesthesiology       Date:  1971-06       Impact factor: 7.892

6.  First pass uptake of fentanyl, meperidine, and morphine in the human lung.

Authors:  D L Roerig; K J Kotrly; E J Vucins; S B Ahlf; C A Dawson; J P Kampine
Journal:  Anesthesiology       Date:  1987-10       Impact factor: 7.892

7.  Pulmonary extraction of [3H]bupivacaine: modification by dose, propranolol and interaction with [14C]5-hydroxytryptamine.

Authors:  P Rothstein; J S Cole; B R Pitt
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.